TERRE HAUTE, Ind. (WTHI)- The FDA has introduced the first generic Narcan nasal spray.
Medical professionals have used the injectable version for years to revive patients of an opioid overdose.
The new option will allow individuals who are not medical professionals to administer the life-saving medication.
Vickie Sanquenetti is a recovering drug addict who highly disagrees with the introduction of this.
"I'm a recovered addict. I've got friends that are still fighting the battle with addiction and I have seen many people that I know and many people that I love transition from prescription drugs to heroin. It's just an on-going battle and it just breaks my heart," said Sanquenetti.
The spray would release into the nasal passage while the patient is lying on his or her back and the effects of an overdose would be reversed within minutes.
Hamilton Center Chief medical officer Ahsan Mahmood told News 10 this new spray is meant to help addicts.
"Improving access of the life-saving medicine is the goal. So it can be in more hands and it can be more available to more individuals and it's administered on time so more lives can be saved. So improving access to saving lives it's going to be the benefit of this generic version," said Mahmood.
Sanquenetti told us she appreciates the FDA making an effort to help but feels it will do the exact opposite.
"No. Absolute no-go. I think it's an enabler. This is just going to encourage people to get even higher and knock on death's door a lot more. I really think we will lose people a lot more because the numbers rise on a daily basis. We're losing people left and right," said Sanquenetti.
Chief Mahmood recommends that patients who use the spray after an overdose should still seek medical attention immediately.
- 'I'm against it..it's an enabler' A recovering drug addict shares her thoughts on an FDA approved generic Narcan nasal spray
- CVS nasal spray recalled due to "microbiological contamination" fears
- FDA approves first postpartum depression drug
- It's OK to use nasal spray flu vaccine again, US panel says
- FDA approves preventive migraine treatment
- FDA approves powerful new opioid
- FDA plans to ease OTC approvals for some prescription drugs
- State awards grants for narcan
- Governor Holcomb shares his thoughts on Indiana's gaming bill
- First FDA-approved cannabis-based drug now available in the US